GFPT2 and colonic neoplasm: Overexpression of a protease competing with macrophages for glutamine in colon cancer cells [glutamine-fructose-6-phosphate transaminase 2 (GFPT2)] can impair mitochondrial fission in macrophages, leading to a weakened phagocytic response and drug resistance [70].